expectations_redefined

CMC Biologics Expands its Production Facility and Rebrands its Corporate Identity

Copenhagen, Denmark/Seattle, Wash., June 22, 2011 -– CMC Biologics today announced that it is in the final stages of expanding its stainless steel biopharmaceutical production facility at its Bothell campus and has rebranded its corporate identity with an exciting new logo and compelling tagline. These recent changes are part of the continued growth of the company.

The Company is completing the expansion of its state-of-the-art stainless steel biopharmaceutical manufacturing facility, known as PF2, to increase capacity and support commercial manufacturing with the addition of a 3,000 liter bioreactor train. The modification of PF2 is part of a staged major expansion plan that started with the construction of a multi-purpose single-use facility (PF1), completed in 2010, and is expected to include the build-out of a facility to house 5,000 liter commercial-ready manufacturing lines.

"We measure our success by the results we deliver to our customers," said Gustavo F. Mahler, Ph.D., Global Chief Operations Officer of CMC Biologics. "The expansion of PF2 will add significant production capacity to CMC Biologics' existing facilities to accommodate growing demand for cGMP manufacture of biopharmaceuticals."

"The rebranding, which coincides with the Company's tenth anniversary, isn't just about a new logo. It's about our reputation and image in the market," noted Claes Glassell, CEO of CMC Biologics. "The new tagline 'Right. On Time.' conveys our commitment to our customers."

About CMC Biologics
CMC Biologics (www.cmcbio.com) is a leading contract development organization that provides fully integrated biopharmaceutical development and manufacturing services to clients around the world, from its facilities in Europe and the USA. The Company specializes in custom services for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and in-market API production. CMC Biologics' wide range of integrated services includes cell line development using its proprietary CHEF1® system, process development and best in class comprehensive analytical and characterization services. CMC Biologics has fully segregated microbial and mammalian cell culture suites and offers both stirred tank and perfusion processes. CMC Biologics is located in Copenhagen, Denmark and Bothell, Washington near Seattle, USA.

Media contact:
Leah Grant
206.660.4003
This email address is being protected from spambots. You need JavaScript enabled to view it.